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the patients value their physical function less than actually shown in the
performance-tests.
Conclusion: The preoperative variation in levels of pain and functional
limitations in THA patients was high. The conservative treatment modali-
ties given the patients in the pre-surgery phases were not in accordance
with international recommendations. Only 50% of the patients had received
exercise therapy or advice about physical activity prior to surgery.
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Purpose: To study the prevalence of knee osteoarthritis (OA) in patients
with somatic pathology and to assess the impact of combined drug therapy
of chondroitin sulfate and glucosamine (ARTRA) on the course of OA and
somatic pathology.
Methods: A screening of 1200 patients with various somatic diseases
was performed to reveal the knee OA. The group of 60 patients with
somatic pathology and knee OA was formed to participate in a comparative
randomized study investigating the effectiveness and safety of the therapy
with ARTRA. The level of pain (VAS, WOMAC), a functional insuﬃciency
(WOMAC), data, esophagogastroduodenoscopy, blood pressure, frequency
of episodes of painful and painless myocardial ischemia, as well as the
frequency of rehospitalizations during the year were evaluated in dynamics.
Results: It was shown that over two thirds of the patients aged 60 years
with chronic somatic diseases suffer from pain in the knee or hip joints,
and 60% of them have radiological signs of OA. It was found that in many
cases the aggravation of the articular syndrome is preceded by exacerbation
of underlying disease (hypertension, ischemic heart disease, heart failure,
etc.). Evaluation of the therapy received by these patients, showed that
71.3% of them had to take NSAIDs, and medications containing chondroitin
sulfate and glucosamine, were taken only by 4.5% of patients. Inclusion of
arthritis drug therapy in patients with OA and somatic pathology allowed
reaching the pain-relieving effect and improving the functional state of the
joints faster compared with the patients receiving only NSAID. Besides, the
use of ARTRA reduced the risk of complications in the gastrointestinal tract
(data esophagogastroduodenoscopy), reduced the risk of destabilization of
somatic diseases (CHD, hypertension, etc.), as well as reduced treatment
costs (including the reduce of number of hospitalizations).
Conclusions: The ﬁndings suggest the need for screening of OA in patients
with somatic pathology, especially in people aged over 60 years. The use of
slow anti-inﬂammatory drugs with a structurally modifying action (ARTRA)
in treatment of OA improves the results of articular pathology treatment as
well as somatic state of patients.
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Purpose: Treatment guidelines for hip and knee osteoarthritis (OA) rec-
ommend information, exercise and weight control as ﬁrst line treatments.
However, recommendations are given in general terms that are not easy to
implement and the interpretation of the rcommendations are not always
straightforward for the care giver. Consequently, they are too seldom
reﬂected in clinical practice. In fact, patients with hip or knee OA are
often referred to surgery before having evidence-based non-surgical core
treatments adequately tried.
Methods: During 2008 a national programme was introduced in Sweden
to standardize and improve care and management of patients with hip
or knee OA; Better management of patients with OsteoArthritis (BOA
www.boaregistret.se). The intervention is a self-management course for
patients with hip or knee OA, including information on pathology, etiology,
available treatments, and coping strategies (Fig 1). An exercise program is
optional, given individually or in a group. Furthermore, one of the three
theoretical classes is held by an osteoarthritis communicator, i.e. a patient
with OA who has been educated to teach about the lived experience with
OA.
Physical therapists, who have been trained during a two-day instructional
course, deliver and evaluate the BOA intervention in a standardized way.
Patient-reported outcome measures (PROM), including EQ-5D, co morbid-
ity, pain, physical activity, self-eﬃcacy, work capacity, and satisfaction, are
assessed at baseline, 3 and 12 months (Fig. 1). Compliance to intervention
is reported by the physical therapist.
Figure 1. Flow-chart of intervention and follow-up in the Better management of os-
teoarthritis programme (www.boaregistret.se).
Results: These outcomes are registered in a national database, the BOA-
register that now includes 25 care giving units. More units continuously
join the registry. Preliminary results from 1000 patients at three months
show that 87% consider the course to fulﬁl their expectations, and 64% use
what they have learned in their daily life.
Conclusions: This new approach, a structural way to take care of patients
with hip and knee joint OA, will provide population-based data and demo-
graphics to optimize clinical care. Furthermore, merging the BOA-register
with other Swedish national registers enables evaluation of use of medical
care, arthroscopic surgery, knee MR examination, use of medication, as well
as sick leave for patients with OA participating in the BOA intervention
compared to non-participants.
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Purpose: Rupture of the anterior cruciate ligament (ACL) is a common
sports related injury, that has an annual incidence varying of 2- 8 per
10.000 persons. Several studies showed that 50 - 85% of patients with an
ACL rupture had slight-to-moderate radiographic changes at 12 to 20 years
after trauma.
The pathophysiology of an ACL rupture leading to evident radiologic knee
osteoarthritis (OA) still remains largely unknown. Therefore, the overall aim
of this study is to investigate early degenerative changes in patients with
an acute ACL rupture. These changes will be evaluated by several sensitive
measurements for OA (MRI, radiographs, DEXA scan and biomarkers).
Methods: Design and study population: The KNALL (KNee osteoArthritis
anterior cruciate Ligament Lesion) study is a prospective follow-up study
in which 160 patients will be included. The patients will be included after
the initial trauma up to 6 months and evaluated each year, in ﬁrst instance
up to 2 years. Patients aged between18 and 45 years with an ACL rupture
(diagnosed by physical examination and MRI) will be included. Patients
